Cogent Biosciences, Inc. announced the appointment of Brad Barnett as Chief Technology Officer (CTO). In his new role, Mr. Barnett will be responsible for all aspects of chemistry, manufacturing and controls (CMC), technical development, supply chain operations, and alliance management. Mr. Barnett is a deeply experienced technical operations executive with a demonstrated knowledge of the pharmaceutical industry. His extensive career includes nearly 20 years at Array BioPharma where he most recently served as Vice President of Supply Chain & Manufacturing. Mr. Barnett joined Array in 2000, two years after the company was founded, and played an invaluable role in successfully bringing Mektovi and Braftovi, two precision oncology medicines, to market while serving in a range of roles including research, business development and technical operations. Prior to joining Cogent, he led the Mektovi and Braftovi manufacturing integration into Pfizer following Pfizer's acquisition of Array.